SINOVAC BIOTECH LTD (SVA) › Cost of RevenueSINOVAC BIOTECH LTD (SVA) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2009: $20.06M2010: $16.72M2011: $21.13M2012: $19.10M2013: $20.50M2014: $15.48M2015: $18.41M2016: $22.39M2017: $20.24M2018: $24.72M2019: $32.47M2020: $67.18M2021: $988.92M2022: $658.19M2023: $146.85M2024: $140.69M2025: $124.03M$124.03M2009Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$124.03M-11.8%2024$140.69M-4.2%2023$146.85M-77.7%2022$658.19M-33.4%2021$988.92M+1372.0%2020$67.18M+106.9%2019$32.47M+31.3%2018$24.72M+22.1%2017$20.24M-9.6%2016$22.39M+21.6%2015$18.41M+18.9%2014$15.48M-24.5%2013$20.50M+7.4%2012$19.10M-9.6%2011$21.13M+26.4%2010$16.72M-16.7%2009$20.06M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share